HEMOSTATIC CHANGES IN PNEUMONIA IN YOUNG CHILDREN
Abstract
The development of pneumonia is strongly influenced by viral–bacterial mixed infections, environmental factors, immaturity of the immune system, and cytokine imbalance. It has been demonstrated that the intensification of the inflammatory process leads to endothelial damage, microcirculatory disorders, and activation of intravascular coagulation, thereby increasing the risk of hypercoagulation and disseminated intravascular coagulation (DIC). Changes in fibrinogen, prothrombin, and fibrinolysis markers are highlighted as important laboratory indicators for assessing the severity of pneumonia. Modern diagnostic approaches-comprehensive evaluation of immunological and hemostasiological tests-play a crucial role in early diagnosis, prevention of complications, and improving treatment effectiveness.
References
1 Abraham E. Coagulation abnormalities in acute lung injury and sepsis. Am J Respir Cell Mol Biol. 2000;22:401-4.
2 Agapakis DI, Tsantilas D, Psarris P, et al. Coagulation and inflammation biomarkers may help predict the severity of community-acquired pneumonia. Respirology. 2010;15:796-803.
3 Arslan S, Ugurlu S, Bulut G, Akkurt I. The association between plasma D-dimer levels and community-acquired pneumonia. Clinics. 2010;65:593-7.
4 Bartlett JG, Dowell SF, Mandell LA, File TM Jr, Musher DM, Fine MJ. Practice guidelines for the management of community-acquired pneumonia in adults. Clin Infect Dis. 2000;31:347-82.
5 Barkagan Z. S., Momot A. G. Gemostaz buzilishlarining diagnostikasi va nazorat qilinadigan terapiyasi. M.: Nyodiamsd, 2001. 296 p.
6 Brusentsova T. S., Smirnov A. K., Poluxin D. G. Gemostatik kasalliklarni hisobga olgan holda bolalarda o'tkir yiringli destruktiv pnevmoniyani davolash tajribasi. In: Mingyillik boshidagi Oltoy pediatriyasi: Proc. ilmiy-amaliy. Butunrossiya konf. xalqaro ishtirokida, Oltoy davlat tibbiyot universiteti pediatriya fakultetining 45 yilligiga bag'ishlangan, Barnaul; 2011. p. 38-41.
7 Dassner AM, Nicolau DP, Girotto JE. Management of pneumonia in the pediatric critical care unit: an area for antimicrobial stewardship. Curr Pediatr Rev. 2017;13(1):49–66. doi: 10.2174/1573396312666161205102221
8 De Pascale G, Bello G, Tumbarello M, Antonelli M. Severe pneumonia in intensive care: cause, diagnosis, treatment and management: a review of the literature. Curr Opin Pulm Med. 2012;18(3):213–221. doi: 10.1097/MCP.0b013e328351f9bd
9 Günther A, Mosavi P, Heinemann S, et al. Alveolar fibrin formation caused by enhanced procoagulant and depressed fibrinolytic capacities in severe pneumonia. Comparison with the acute respiratory distress syndrome. Am J Respir Crit Care Med. 2000;161:454-62.
10 Gupta GR. Tackling pneumonia and diarrhoea: the deadliest diseases for the world's poorest children. Lancet. 2012 Jun 09;379(9832):2123-4.
11 Kuznik B. I., Tsybikov N. N. Gemostaz tizimini tartibga solishning otoimmun mexanizmlari. Sibir onkologik jurnali. 2005;13(1):88–95.
12 Levi M, Schultz MJ, Rijneveld AW, van der Poll T. Bronchoalveolar coagulation and fibrinolysis in endotoxemia and pneumonia. Crit Care Med. 2003;31:238-42.
13 Nieuwenhuizen L, de Groot PG, Grutters JC, Biesma DH. A review of pulmonary coagulopathy in acute lung injury, acute respiratory distress syndrome, and pneumonia. Eur J Haematol. 2009;82:413-25.
14 Petäjä J. Inflammation and coagulation. An overview. Thromb Res. 2011;127:34-7.
15 Rudan I, Nair H, Marušić A, Campbell H. Reducing mortality from childhood pneumonia and diarrhoea: The leading priority is also the greatest opportunity. J Glob Health. 2013 Jun;3(1):010101.
16. Tauber MG. [Pneumonia: what’s new?]. Schweiz Med Wochenschr. 1999;129(14):563–569.
17. Wang X, Lin X. Analysis of clinical related factors of severe mycoplasma pneumoniae pneumonia in children based on imaging diagnosis. Comput Math Methods Med. 2022;2022:4852131. doi: 10.1155/2022/4852131
